Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 231 participants.
Also called NCT02833948
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 231 participants
- Registry
-
NCT02833948
-
- Other papers using this trial's data
- Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Denmark, Germany, Netherlands, Sweden, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT02833948. Randomized; single masking; primary purpose diagnostic. Start 2016-05 (registry gives no type); primary completion 2018-12 (actual). Results posted on 2020-01-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)
- Acronym
- GALILEO-4D
- Condition
- Aortic Valve Stenosis
- Condition
- Cardiovascular Diseases
- Condition
- Heart Valve Diseases
- Condition
- Ventricular Outflow Obstruction
- Condition
- Thrombosis
- Intervention (Drug)
- Acetylsalicylic acid
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Rivaroxaban
- Lead sponsor
- ECRI bv
- Collaborator
- Copenhagen University Hospital, Rigshospitalet
- Collaborator
- Bayer
- Collaborator
- Cardialysis BV
Record details
- Record id
cardio:ct-nct02833948- Content hash
1d660771d11f354c419bc1395c194269b393f2de41d4119265df73574f209653